Arginine butyrate downregulates p210 bcr-abl expression and induces apoptosis in chronic myelogenous leukemia cells

Leukemia

Volumn 12, Issue 6, 1998, Pages 930-936

  Urbano, A ^a   Koc, Y ^a   Foss, F M ^a,b  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Bcr abl; Butyrate; CML

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BUTYRIC ACID; ONCOPROTEIN; PHOSPHOPROTEIN; PROTEIN KINASE;

APOPTOSIS; ARTICLE; CELL STRAIN K 562; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

EID: 0031805932     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401031     Document Type: Article

References (18)

1. Kruh J. Effects of sodium bulyrate, a new pharmacological agent, on cells in culture. Mol Cell Biochem 1982; 42: 65-82.
2. Gamet L, Daviaud D, Denis-Pouxviel C, Remesy C, Murat J. Effects of short-chain fatty acids on growth and differentiation of the human colon-cancer cell line HT29. Int J Cancer 1992; 52: 286-289.
3. Nakagawa T, Nelkin B, Baylin S, de Bustros A. Transcriptional and post-transcriptional modulation of calcitonin gene expression by sodium butyrate in cultured human medullary thyroid carcinoma. Cancer Res 1988; 48: 2096-2100.
4. Murphy LD, Valverius EM, Tsokos M, Mickley LA, Rosen N, Bates S. Modulation of EGF receptor expression by differentiating agents in human colon carcinoma cell lines. Cancer Commun 1990; 2: 345-355.
5. Fischkoff SA, Hoessly MC, Rossi RM. Characterization of sublines of HL-60 resistant to differentiation by butyric acid. Leukemia 1990; 4: 302-306.
6. Calabresse C, Venturini L, Ronco G, Villa P, Degos L, Belpomme D, Chomienne C. Selective induction of apoptosis in myeloid leukemia cell lines by monoacetone glucose-3 butyrate. Biochem Biophys Res Comm 1994; 201: 266-283.
7. Filippovich I, Sorokina N, Khanna K, Lavin M. Butyrate induced apoptosis in lymphoid cells preceded by transient over-expression of HSP70 mRNA. Biochem Biophys Res Comm 1994; 198: 257-265.
8. Martin S, Lennon S, Bonham A, Cotter T. Induction of apoptosis (programmed cell death) in human leukemic cells by inhibitors of RNA or protein synthesis. J Immunol 1990; 145: 1859-1867.
9. McGahon A, Bissonnette R, Schmitt M, Cotter K, Green D, Cotter T. BCR-ABL maintains resistance of chronic myelogeneous leukemia cells to apoptotic death. Blood 1994; 83: 1179-1187.
10. Perrine S, Ginder G, Faller D, Dover G, Ikuta T, Witkowska E, Cai S, Vincinsky E, Olivieri N. A short term trial of butyrate to stimulate fetal globin gene expression in the B-globin disorders. New Engl J Med 1993; 328: 81-86.
11. Wyllie AH, Kerr JR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980; 68: 251-306.
12. Martin S, Bradley J, Cotter T. HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis. Clin Exp Immunol 1990; 79: 448-453.
13. Cotter T, Lennon SV, Glynn JM, Green DR. An intact microfibular network is necessary for the formation of apoptotic bodies in cells undergoing apoptosis. Cancer Res 1992; 52: 997-1005.
14. Gendimenico GJ, Bouquin PL, Tramposch KM. Diphenylamine-colorimetric method for DNA assay: a shortened procedure by incubating samples at 50°C. Anal Biochem 1988; 173: 45-48.
15. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
16. Novogrodsky A, Dvir A, Ravid A, Shkolnik T, Stenzel K, Rubin A, Zaizov R. Effects of polar organic compounds on leukemic cells. Cancer 1983; 51: 9-14.
17. Miller A, Kurschel E, Osieka R, Schmidt C. Clinical pharmacology of sodium butyrate in patients with acute leukemia. Eur J Clin Oncol 1987; 23: 1283-1287.
18. Hague A, Elder D, Hicks D, Paraskeva C. Apoptosis in colorectal tumour cells: induction by the short chain fatty acids butyrate, propionate, and acetate and by the bile salt deoxycholate. Int J Cancer 1995; 60: 400-406.